QURESH BANDUKWALA: Open Payments
NPI 1124170097 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 6 payments from 5 companies in 2025. Trend: 2023 $827 · 2024 $398 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $54 |
| ABBVIE INC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, Dexcom G6 Transmitter, INVEGA SUSTENNA.
Industry payments across GA — which companies pay providers there.
